These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31134722)

  • 1. Shigella host: Pathogen interactions: Keeping bacteria in the loop.
    Liu G; Pilla G; Tang CM
    Cell Microbiol; 2019 Nov; 21(11):e13062. PubMed ID: 31134722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella infection of intestinal epithelium and circumvention of the host innate defense system.
    Ashida H; Ogawa M; Mimuro H; Sasakawa C
    Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
    Fernandez MI; Sansonetti PJ
    Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Schnupf P; Sansonetti PJ
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953429
    [No Abstract]   [Full Text] [Related]  

  • 5. How Do the Virulence Factors of
    Mattock E; Blocker AJ
    Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular and cellular mechanisms of invasion of the intestinal barrier by enteric pathogens. The paradigm of Shigella.
    Sansonetti PJ
    Folia Microbiol (Praha); 1998; 43(3):239-46. PubMed ID: 9717250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion.
    Xu D; Liao C; Zhang B; Tolbert WD; He W; Dai Z; Zhang W; Yuan W; Pazgier M; Liu J; Yu J; Sansonetti PJ; Bevins CL; Shao Y; Lu W
    Immunity; 2018 Jun; 48(6):1233-1244.e6. PubMed ID: 29858013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes.
    Killackey SA; Sorbara MT; Girardin SE
    Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of Shigella: the study of bacteria-host interplay at the intestinal mucosal barriers].
    Sasakawa C
    Nihon Saikingaku Zasshi; 2012; 67(4):257-68. PubMed ID: 23269180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella are versatile mucosal pathogens that circumvent the host innate immune system.
    Ashida H; Ogawa M; Mimuro H; Kobayashi T; Sanada T; Sasakawa C
    Curr Opin Immunol; 2011 Aug; 23(4):448-55. PubMed ID: 21763117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inside story of Shigella invasion of intestinal epithelial cells.
    Carayol N; Tran Van Nhieu G
    Cold Spring Harb Perspect Med; 2013 Oct; 3(10):a016717. PubMed ID: 24086068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.
    D'Hauteville H; Khan S; Maskell DJ; Kussak A; Weintraub A; Mathison J; Ulevitch RJ; Wuscher N; Parsot C; Sansonetti PJ
    J Immunol; 2002 May; 168(10):5240-51. PubMed ID: 11994481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
    Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
    Phalipon A; Sansonetti PJ
    Immunol Cell Biol; 2007; 85(2):119-29. PubMed ID: 17213832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The versatility of Shigella effectors.
    Ogawa M; Handa Y; Ashida H; Suzuki M; Sasakawa C
    Nat Rev Microbiol; 2008 Jan; 6(1):11-6. PubMed ID: 18059288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Enteric Defensin 5 Promotes
    Xu D; Liao C; Xiao J; Fang K; Zhang W; Yuan W; Lu W
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Intestinal Enteroids as a Model System of
    Koestler BJ; Ward CM; Fisher CR; Rajan A; Maresso AW; Payne SM
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shigella: from the rupture to the invasion and to the destruction of the colonic epithelium].
    Sansonetti P
    Presse Med; 2000 Dec; 29(37):2040-1. PubMed ID: 11155729
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Brunner K; Samassa F; Sansonetti PJ; Phalipon A
    Hum Vaccin Immunother; 2019; 15(6):1317-1325. PubMed ID: 30964713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.